In the Original Article titled “Association of 70-Gene Signature Assay Findings With Physicians’ Treatment Guidance for Patients With Early Breast Cancer Classified as Intermediate Risk by the 21-Gene Assay,”1 published online October 26, 2017, information about the Open Access status was added to the acknowledgments. This article has been corrected online.
Reference
- 1.Tsai M, Lo S, Audeh W, et al. Association of 70-gene signature assay findings with physicians’ treatment guidance for patients with early breast cancer classified as intermediate risk by the 21-gene assay [published online October 26, 2017]. JAMA Oncol. doi: 10.1001/jamaoncol.2017.3470 [DOI] [PMC free article] [PubMed] [Google Scholar]